Poy E
Sanofi Recherche, Gentilly, France.
Qual Assur. 1993 Dec;2(4):326-31.
Over the recent years, the concept of Good Clinical Practice (GCP) has rapidly evolved over the world, with guidelines and regulations now existing not only in the U.S.A. but also in Europe, Scandinavia, Japan, and Australia. The systematic measures laid down in GCP are to ensure that clinical studies are conducted in conformity with strict ethical rules, are performed according to high-quality standards, and result in authentic, verifiable scientific data. Different aspects in managing quality in the clinical field are to be presented: (1) The definition of a two-stage quality system: it identifies the differences between quality control activities which reside with the operational units and auditing activities performed by an independent Quality Assurance group, which assesses the efficiency and integrity of the control systems established to ensure the quality. (2) The multidisciplinary picture of a clinical study: every operational staff contributes to quality through a chain using the "quality in/quality out" concept. (3) The review of the main responsibilities of the main professionals (Sponsor, Monitor, and Investigator) in a GCP environment, to show that quality is achievable by involving appropriate qualified staff. (4) The need of proactive control systems to reduce the risk of error and increase the credibility and confidence in building quality. (5) The role and objectives of a Quality Assurance Group.
近年来,良好临床规范(GCP)的概念在全球迅速发展,如今不仅在美国,而且在欧洲、斯堪的纳维亚、日本和澳大利亚都有相关指南和法规。GCP中规定的系统性措施旨在确保临床研究按照严格的道德规则进行,依据高质量标准开展,并产生真实、可验证的科学数据。本文将阐述临床领域质量管理的不同方面:(1)两阶段质量体系的定义:它明确了运营单位所进行的质量控制活动与独立质量保证小组所开展的审核活动之间的差异,质量保证小组负责评估为确保质量而建立的控制系统的效率和完整性。(2)临床研究的多学科概况:每个运营人员都通过运用“质量进/质量出”的概念,在一个链条中为质量做出贡献。(3)在GCP环境下对主要专业人员(申办者、监查员和研究者)主要职责的审查,以表明通过让适当的合格人员参与能够实现质量目标。(4)需要积极主动的控制系统来降低错误风险,并增强建立质量过程中的可信度和信心。(5)质量保证小组的作用和目标。